"We are very pleased with our early Phase 3 biomarker data highlighting their importance as important tools in BriaCell's fight against metastatic breast cancer, a difficult to treat and deadly ...

which has so far included work on a custom AI tool. The next phase of the ABC’s AI strategy could be revealed to staff as soon as next week. AAP/Danny Casey. The ABC is putting the finishing touches ...

This article proposes a copper loss reduced fault-tolerant strategy by utilizing zero-sequence torque for one phase open failure. To regulate the zero-sequence current, the neutral point is connected ...

Researchers from the University of Eastern Finland, Aalto University and the University of Oulu have developed a new ...

A team of engineers at the University of California San Diego is making it easier for researchers from a broad range of ...

Management outlined plans to complete the CTA process for ABCL635 and ABCL575 within Q2 2025, with Phase 1 trials starting in Q3 2025. Key readouts for safety and efficacy are anticipated in mid-2026 ...

Over 75 patients enrolled in BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune ... and clinical investigator interest in our Bria-ABC study is above any I have seen,” noted Giuseppe ...

Three corrections officers at Wallens Ridge State ... who were in this country illegally," according to a press release provided to ABC News. Each of the suspects have been convicted of violent ...

El Paso, TX (KVIA-TV)- UTEP's program manager, Socorro Herrera, joins us to discuss the UTEP Kidz on Campus event. You can visit UTEP’s Memorial Gym on May 3rd, between 10 a.m. and 2 p.m., and ...

The Swiss drugmaker is making the outlay, around half of which is upfront, to buy Regulus Therapeutics for a rare renal disease drug that is set to enter phase 3 in the third quarter. Regulus ...